| Date | Title | Description | Source |
| 02.04.2024 | Jay Appel, Chief Innovation & Growth Officer at The Bloc... | NEW YORK, April 2, 2024 /PRNewswire/ -- The Bloc, a renowned global health-native agency, is proud t... | salamancap... |
| 05.03.2024 | MannKind Announces New Clinical Data From Inhale-3 Study to ... | - | globenewsw... |
| 09.11.2021 | Mannkind Corporation Closes Sale-Leaseback Transaction Gener... | WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation ... | globenewsw... |
| 09.11.2021 | Mannkind Corporation Closes Sale-Leaseback Transaction Gener... | WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation ... | marketscre... |
| 29.09.2021 | Mannkind Corporation Announces Sale-Leaseback Transaction Ge... | WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 29, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation... | marketscre... |
| 04.08.2021 | NRx Pharmaceuticals : Partners with MannKind Corporation to ... | RADNOR, Pa., Aug. 4, 2021 /PRNewswire/ -- NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) announced today i... | marketscre... |
| 28.06.2021 | Policy Change Allows Approval For Medicare Patients Living W... | | prnewswire... |
| 03.06.2021 | MannKind Announces Data Presentation At 14th International C... | | prnewswire... |
| 13.05.2021 | MannKind Announces Partnership With Type 1 Diabetes IndyCar ... | | prnewswire... |
| 30.12.2014 | Maker of inhalable insulin marches on in wake of scrapped IP... | This isn’t the first time a company’s attempted an airborne diabetes med – yet there’s currently a h... | medcitynew... |
| 13.08.2013 | From inhalable insulin to vaccines: 5 diabetes companies to ... | Then there’s Pepex Biomedical, which is developing a line of all-in-one blood glucose meters that us... | medcitynew... |
| 01.07.2013 |
MannKind Gets $160M In Debt Funding
| Valancia-based MannKind, which provides discovery, development, and commercialization of therapeutic... | socaltech.... |
| 26.04.2012 | Avandia to Alogliptin: A time line of recent FDA actions on ... | July 2010: An FDA advisory panel holds a two-day meeting to discuss safety issues surrounding GSK’s ... | medcitynew... |
| 12.10.2009 | FDA to consider small inhaler for diabetes patients – MedC... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems stri... | medcitynew... |
| - | FDA to consider small inhaler for diabetes patients – MedC... | Image via Wikipedia
People with diabetes soon may be able to use a discreet device to inhale, rather... | medcitynew... |
| - | From inhalable insulin to vaccines: 5 diabetes companies to ... | With an estimated 370 million people expected to have diabetes by 2030, the already $41 million mark... | medcitynew... |
| - | Maker of inhalable insulin marches on in wake of scrapped IP... | It’s a drug meant for the injection-weary diabetic set: Dance Biopharm‘s developing an inhalable for... | medcitynew... |
| - | Avandia to Alogliptin: A time line of recent FDA actions on ... | Diabetes drug alogliptin fell short of U.S. Food and Drug Administration approval on Wednesday, deal... | medcitynew... |
